000			01960 a2200517 4500
005			20250516041058.0
264		0	_c20120507
008			201205s 0 0 eng d
022			_a1523-6536
024	7		_a10.1016/j.bbmt.2011.05.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aNivison-Smith, Ian
245	0	0	_aAllogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk. _h[electronic resource]
260			_bBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _cFeb 2012
300			_a302-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAustralia _xepidemiology
650	0	4	_aChronic Disease
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNew Zealand _xepidemiology
650	0	4	_aPrimary Myelofibrosis _xmortality
650	0	4	_aRegistries
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aTransplantation Conditioning _xadverse effects
650	0	4	_aTransplantation, Homologous
700	1		_aDodds, Anthony J
700	1		_aButler, Jason
700	1		_aBradstock, Kenneth F
700	1		_aMa, David D F
700	1		_aSimpson, Judy M
700	1		_aSzer, Jeff
773	0		_tBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _gvol. 18 _gno. 2 _gp. 302-8
856	4	0	_uhttps://doi.org/10.1016/j.bbmt.2011.05.003 _zAvailable from publisher's website
999			_c20881256 _d20881256